For hepatocellular carcinoma, associations included CDK2-TXN2 (neg), CDK2-TXNRD2 (neg), CDK2-FOXM1 (pos), CDK2-CSNK2A1 (gene for CK2) (pos), CDK2-HIF1 (pos), CDK4-PRDX3 (neg), CDK4-CSNK2A1 (pos), CDK4-CSNK2B (pos), CDK5-GLRX2 (pos), CDK5-NFKB1 (neg), CDK5-CSNK2B (pos), CDK5-HIF1 (neg), TXN-TXNRD1 (pos), TXN-GLRX2 (pos), TXN-GPX2 (pos), TXN-SOD2 (pos), TXN2-NFKB1 (neg), TXN-CSNK2B (pos), TXN2-TXNRD2 (pos), TXN2-NFKB1 (neg), TXN2-CSNK2A1 (neg), TXN2-CSNK2B (pos), HIF1-TXN (neg), HIF1-TXN2 (neg), HIF1-TXNRD2 (neg), HIF1-NFKB1 (pos), HIF1-CSNK2A1 (pos), and HIF1-CSNK2B (neg). This evidence concerns the gene GLRX2 and hepatocellular carcinoma.